# K981687: Quickscreen Benzodiazepines Screening Test Model Numbers 9025,9026 and Quickscreen Pro Multi Drug Screening Test Model 1

- Pathway: 510(k) (Traditional)
- Applicant: Phamatech
- Decided: Jun 3, 1998 after 21 days
- Product code: JXM (Enzyme Immunoassay, Benzodiazepine)
- Device class: 2
- Regulation: 21 CFR 862.3170
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) ABMC: named in the summary without a submission number
- (no number) Applied Biotech SureStep Test: named in the summary without a submission number

## Indications for use
An in vitro diagnostic test for the qualitative identification of benzodiazepines in urine. Measurements obtained by this device are used in the diagnosis and treatment of drug abuse.

Source page: https://510kreport.com/device/K981687
Methodology: https://510kreport.com/methodology